• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Systemic cytotoxic and biologic therapies for colorectal cancer liver metastases: expert consensus statement.

作者信息

Clary Bryan M, Grothey Axel, Kopetz Scott, Marsh Robert D W

机构信息

Department of Surgery, Duke University Medical Center, Durham, NC 27710, USA.

出版信息

HPB (Oxford). 2013 Feb;15(2):116-8. doi: 10.1111/j.1477-2574.2012.00598.x.

DOI:10.1111/j.1477-2574.2012.00598.x
PMID:23297722
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3719917/
Abstract
摘要

相似文献

1
Systemic cytotoxic and biologic therapies for colorectal cancer liver metastases: expert consensus statement.结直肠癌肝转移的全身细胞毒性和生物治疗：专家共识声明
HPB (Oxford). 2013 Feb;15(2):116-8. doi: 10.1111/j.1477-2574.2012.00598.x.
2
Locoregional surgical and interventional therapies for advanced colorectal liver metastasis: expert consensus statement.晚期结直肠癌肝转移的局部区域手术及介入治疗：专家共识声明
HPB (Oxford). 2013 Feb;15(2):131-3. doi: 10.1111/j.1477-2574.2012.00565.x.
3
Systemic cytotoxic and biological therapies of colorectal liver metastases: expert consensus statement.结直肠癌肝转移的全身细胞毒性和生物治疗：专家共识声明。
HPB (Oxford). 2013 Feb;15(2):106-15. doi: 10.1111/j.1477-2574.2012.00558.x. Epub 2012 Sep 24.
4
Improving resectability of hepatic colorectal metastases: expert consensus statement.提高肝结直肠癌转移灶的可切除性：专家共识声明
Ann Surg Oncol. 2006 Oct;13(10):1271-80. doi: 10.1245/s10434-006-9045-5. Epub 2006 Sep 6.
5
Improving resectability of hepatic colorectal metastases: expert consensus statement by Abdalla et al.提高肝结直肠癌转移灶的可切除性：阿卜杜拉等人的专家共识声明
Ann Surg Oncol. 2006 Oct;13(10):1281-3. doi: 10.1245/s10434-006-9149-y. Epub 2006 Sep 9.
6
Managing colorectal cancer liver metastases.结直肠癌肝转移的管理。
Oncology (Williston Park). 2009 Nov 15;23(12):1063-71.
7
AHPBA/SSO/SSAT sponsored consensus conference on the multidisciplinary treatment of colorectal cancer metastases.美国病理学家协会/外科肿瘤学会/肉瘤肿瘤学会主办的关于结直肠癌转移多学科治疗的共识会议。
HPB (Oxford). 2013 Feb;15(2):89-90. doi: 10.1111/j.1477-2574.2012.00569.x.
8
Locoregional surgical and interventional therapies for advanced colorectal cancer liver metastases: expert consensus statements.局部区域外科和介入治疗晚期结直肠癌肝转移：专家共识声明。
HPB (Oxford). 2013 Feb;15(2):119-30. doi: 10.1111/j.1477-2574.2012.00597.x.
9
SEOM clinical guidelines for diagnosis and treatment of metastatic colorectal cancer (2018).SEOM 临床指南：转移性结直肠癌的诊断和治疗（2018）。
Clin Transl Oncol. 2019 Jan;21(1):46-54. doi: 10.1007/s12094-018-02002-w. Epub 2018 Dec 18.
10
Liver-directed therapies in colorectal cancer.结直肠癌的肝脏导向治疗。
Semin Oncol. 2011 Aug;38(4):561-7. doi: 10.1053/j.seminoncol.2011.05.010.

引用本文的文献

1
Protocol for Combined Analysis of FOXFIRE, SIRFLOX, and FOXFIRE-Global Randomized Phase III Trials of Chemotherapy +/- Selective Internal Radiation Therapy as First-Line Treatment for Patients With Metastatic Colorectal Cancer.FOXFIRE、SIRFLOX和FOXFIRE-全球转移性结直肠癌患者一线化疗+/-选择性体内放射治疗随机III期试验联合分析方案
JMIR Res Protoc. 2017 Mar 28;6(3):e43. doi: 10.2196/resprot.7201.
2
Selective Internal Radiation Therapy (SIRT) with yttrium-90 resin microspheres plus standard systemic chemotherapy regimen of FOLFOX versus FOLFOX alone as first-line treatment of non-resectable liver metastases from colorectal cancer: the SIRFLOX study.钇-90树脂微球选择性内放射治疗（SIRT）联合FOLFOX标准全身化疗方案与单纯FOLFOX作为不可切除结直肠癌肝转移一线治疗的比较：SIRFLOX研究
BMC Cancer. 2014 Dec 1;14:897. doi: 10.1186/1471-2407-14-897.

本文引用的文献

1
Systemic cytotoxic and biological therapies of colorectal liver metastases: expert consensus statement.结直肠癌肝转移的全身细胞毒性和生物治疗：专家共识声明。
HPB (Oxford). 2013 Feb;15(2):106-15. doi: 10.1111/j.1477-2574.2012.00558.x. Epub 2012 Sep 24.
2
Capecitabine plus oxaliplatin compared with 5-fluorouracil plus oxaliplatin in metastatic colorectal cancer: Meta-analysis of randomized controlled trials.卡培他滨联合奥沙利铂与5-氟尿嘧啶联合奥沙利铂治疗转移性结直肠癌的比较：随机对照试验的Meta分析
Oncol Lett. 2012 Apr 1;3(4):831-838. doi: 10.3892/ol.2012.567. Epub 2012 Jan 16.
3
Extended preoperative chemotherapy does not improve pathologic response and increases postoperative liver insufficiency after hepatic resection for colorectal liver metastases.对于结直肠癌肝转移患者，术前延长化疗并不能改善病理反应，反而会增加肝切除术后的肝功能不全发生率。
Ann Surg Oncol. 2010 Nov;17(11):2870-6. doi: 10.1245/s10434-010-1166-1. Epub 2010 Jun 22.
4
Sinusoidal obstruction syndrome and nodular regenerative hyperplasia are frequent oxaliplatin-associated liver lesions and partially prevented by bevacizumab in patients with hepatic colorectal metastasis.窦状隙阻塞综合征和结节性再生性增生是奥沙利铂相关的常见肝脏病变，贝伐珠单抗可部分预防结直肠肝转移患者的此类肝脏病变。
Histopathology. 2010 Mar;56(4):430-9. doi: 10.1111/j.1365-2559.2010.03511.x.
5
A randomized phase III study comparing adjuvant 5-fluorouracil/folinic acid with FOLFIRI in patients following complete resection of liver metastases from colorectal cancer.一项比较氟尿嘧啶/亚叶酸辅助治疗与 FOLFIRI 在结直肠癌肝转移完全切除术后患者中的随机 III 期研究。
Ann Oncol. 2009 Dec;20(12):1964-70. doi: 10.1093/annonc/mdp236. Epub 2009 Jun 30.
6
Chemotherapy, bevacizumab, and cetuximab in metastatic colorectal cancer.转移性结直肠癌的化疗、贝伐单抗和西妥昔单抗
N Engl J Med. 2009 Feb 5;360(6):563-72. doi: 10.1056/NEJMoa0808268.
7
A randomized phase IIIB trial of chemotherapy, bevacizumab, and panitumumab compared with chemotherapy and bevacizumab alone for metastatic colorectal cancer.一项随机 IIIB 期试验：比较化疗、贝伐单抗和帕尼单抗联合治疗与单纯化疗和贝伐单抗治疗转移性结直肠癌的疗效。
J Clin Oncol. 2009 Feb 10;27(5):672-80. doi: 10.1200/JCO.2008.19.8135. Epub 2008 Dec 29.
8
Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial.FOLFOX4围手术期化疗联合手术与单纯手术治疗可切除的结直肠癌肝转移（欧洲癌症研究与治疗组织（EORTC）国际协作组试验40983）：一项随机对照试验
Lancet. 2008 Mar 22;371(9617):1007-16. doi: 10.1016/S0140-6736(08)60455-9.
9
Irinotecan fluorouracil plus leucovorin is not superior to fluorouracil plus leucovorin alone as adjuvant treatment for stage III colon cancer: results of CALGB 89803.伊立替康联合氟尿嘧啶及亚叶酸钙作为Ⅲ期结肠癌辅助治疗并不优于单独使用氟尿嘧啶及亚叶酸钙：癌症和白血病B组89803研究结果
J Clin Oncol. 2007 Aug 10;25(23):3456-61. doi: 10.1200/JCO.2007.11.2144.